ReviewWorld journal of gastroenterology2024

Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis.

Francesca Colapietro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.